Clinical Trials Logo

Clinical Trial Summary

A prospective, multicenter, blind randomized (2:1) controlled study comparing the International Prostate Symptom Score (IPSS) of the Active arm to the IPSS of the control arm at the 3 months follow-up and active arm IPSS score change from time zero to 12 months. Patients in the active arm undergo Butterfly device treatment. Patients in the control arm undergo a sham rigid cystoscopy procedure


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05341661
Study type Interventional
Source Butterfly Medical Ltd.
Contact Vardit Segal, Ph.D.
Phone +972524579178
Email vardit@butterfly-medical.com
Status Recruiting
Phase N/A
Start date April 7, 2022
Completion date March 1, 2028

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04987138 - Safety and Effectiveness Study of the Zenflow Spring System N/A
Completed NCT03856242 - Benign Prostatic Hyperplasia and Ischemic Heart DIsease Phase 4
Recruiting NCT02592473 - Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia N/A
Completed NCT01639794 - Vesitirimâ„¢ in Men Postmarketing Observational Study N/A
Terminated NCT00743184 - Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH) Phase 2
Completed NCT00947882 - A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) Phase 2
Completed NCT01846793 - Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) Phase 3